These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17043637)

  • 21. EGF receptor-mediated, c-Src-dependent, activation of Stat5b is downregulated in mitogenically responsive hepatocytes.
    Guren TK; Ødegård J; Abrahamsen H; Thoresen GH; Susa M; Andersson Y; Østby E; Christoffersen T
    J Cell Physiol; 2003 Jul; 196(1):113-23. PubMed ID: 12767047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor.
    Monaghan-Benson E; McKeown-Longo PJ
    J Biol Chem; 2006 Apr; 281(14):9450-9. PubMed ID: 16461772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling.
    Jo M; Thomas KS; Wu L; Gonias SL
    J Biol Chem; 2003 Nov; 278(47):46692-8. PubMed ID: 12963722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urokinase is a negative modulator of Egf-dependent proliferation and motility in the two breast cancer cell lines MCF-7 and MDA-MB-231.
    Kozlova N; Samoylenko A; Drobot L; Kietzmann T
    Mol Carcinog; 2016 Feb; 55(2):170-81. PubMed ID: 25641046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
    Tang H; Kerins DM; Hao Q; Inagami T; Vaughan DE
    J Biol Chem; 1998 Jul; 273(29):18268-72. PubMed ID: 9660790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo.
    Aguirre Ghiso JA
    Oncogene; 2002 Apr; 21(16):2513-24. PubMed ID: 11971186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
    Amorino GP; Deeble PD; Parsons SJ
    Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor.
    Tice DA; Biscardi JS; Nickles AL; Parsons SJ
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1415-20. PubMed ID: 9990038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
    Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
    Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
    Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.
    Cuadrado A; Garcia-Fernandez LF; Gonzalez L; Suarez Y; Losada A; Alcaide V; Martinez T; Fernandez-Sousa JM; Sanchez-Puelles JM; Munoz A
    J Biol Chem; 2003 Jan; 278(1):241-50. PubMed ID: 12414812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
    Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.
    Yao W; Feng D; Bian W; Yang L; Li Y; Yang Z; Xiong Y; Zheng J; Zhai R; He J
    Amino Acids; 2012 Nov; 43(5):2027-35. PubMed ID: 22476347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor.
    Sandberg T; Ehinger A; Casslén B
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1724-30. PubMed ID: 11297609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
    Mueller KL; Hunter LA; Ethier SP; Boerner JL
    Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
    Aguirre Ghiso JA; Kovalski K; Ossowski L
    J Cell Biol; 1999 Oct; 147(1):89-104. PubMed ID: 10508858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
    Mahabeleshwar GH; Das R; Kundu GC
    J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.
    Larusch GA; Merkulova A; Mahdi F; Shariat-Madar Z; Sitrin RG; Cines DB; Schmaier AH
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H305-20. PubMed ID: 23709605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
    Filardo EJ; Quinn JA; Bland KI; Frackelton AR
    Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.